Skip to main content
Log in

Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy

  • Case Report
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

HMG-CoA reductase inhibitors (statins) are highly effective drugs for prevention of cardiovascular events in high-risk patients. Due to the widespread prescription of these agents, special attention should be given to their rare adverse effects when these may have severe outcomes. Here, we report two cases of localized rhabdomyolysis associated with mononeuropathy in patients taking statins and suggest possible explanations for this uncommon association. Close monitoring for myopathic/neuropathic events is warranted in high-risk patients with pre-existing neuropathies who are taking statins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I

Similar content being viewed by others

References

  1. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 2004; 164: 1427–36

    Article  PubMed  CAS  Google Scholar 

  2. Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005; 165: 725–30

    Article  PubMed  CAS  Google Scholar 

  3. Avogaro A, Guida P, Giorda C, et al. The under-use of statin in type 2 diabetic patients attending diabetic clinics in Italy. Nutr Metab Cardiovasc Dis 2007; 17: 32–40

    Article  PubMed  CAS  Google Scholar 

  4. Antons KA, Williams KD, Baker SK, et al. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006; 119: 400–9

    Article  PubMed  CAS  Google Scholar 

  5. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol 2006; 97: 52C–60C

    Article  PubMed  CAS  Google Scholar 

  6. Kiortsis DN, Filippatos TD, Mikhailidis DP, et al. Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis 2007; 195: 5–16

    Article  Google Scholar 

  7. Baker SK, Tarnopolsky MA. Statin-associated neuromyotoxicity. Drugs Today (Barc) 2005; 41: 267–93

    Article  CAS  Google Scholar 

  8. Tsivgoulis G, Spengos K, Karandreas N, et al. Presymptomatic neuromuscular disorders disclosed following statin treatment. Arch Intern Med 2006; 166: 1519–24

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No funding was used to assist in the preparation of these case reports. The authors have no conflicts of interest that are directly relevant to the content of these reports.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gian Paolo Fadini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fadini, G.P., Manzato, E., Crepaldi, C. et al. Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy. Clin. Drug Investig. 30, 347–350 (2010). https://doi.org/10.2165/11535470-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11535470-000000000-00000

Keywords

Navigation